Cargando…
One‐year clinical experience on the use of Nintedanib in systemic sclerosis
We reviewed 11 patients with systemic sclerosis‐related ILD who were referred to our Scleroderma Unit from January 2020 to January 2021 and started Nintedanib. Non‐specific interstitial pneumonia (NSIP) was prevalent (45%), usual interstitial pneumonia (UIP) and UIP/NSIP pattern were both 27%. Only...
Autores principales: | Magnani, Luca, Spinella, Amelia, Testoni, Sofia, Lumetti, Federica, Scelfo, Chiara, Dardani, Lucia, Bajocchi, Gianluigi, Clini, Enrico, Salvarani, Carlo, Giuggioli, Dilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203787/ https://www.ncbi.nlm.nih.gov/pubmed/37229296 http://dx.doi.org/10.1002/rcr2.1120 |
Ejemplares similares
-
Infections of scleroderma digital ulcers: A single center cohort retrospective study
por: Giuggioli, Dilia, et al.
Publicado: (2021) -
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers
por: Spinella, Amelia, et al.
Publicado: (2022) -
Management of Systemic Sclerosis Patients in the COVID-19 Era: The
Experience of an Expert Specialist Reference Center
por: Spinella, Amelia, et al.
Publicado: (2021) -
Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review
por: Spinella, Amelia, et al.
Publicado: (2023) -
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis
por: Giuggioli, Dilia, et al.
Publicado: (2019)